{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:20:18Z","timestamp":1793334018547,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.jpsychires.2010.11.002","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T04:25:49Z","timestamp":1290572749000},"page":"763-769","source":"Crossref","is-referenced-by-count":25,"title":["Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine"],"prefix":"10.1016","volume":"45","author":[{"given":"Benedicto","family":"Crespo-Facorro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"P\u00e9rez-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olalla","family":"Caseiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obdulia","family":"Mart\u00ednez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MariLuz","family":"Ramirez-Bonilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Maria","family":"Pelayo-Ter\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"V\u00e1zquez-Barquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpsychires.2010.11.002_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.11.002_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2009.09.019","article-title":"Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST)","volume":"115","author":"Boter","year":"2009","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1016\/j.jpsychires.2010.11.002_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11920-008-0034-1","article-title":"Treatment of the first episode of schizophrenia: an update on pharmacologic and psychological interventions","volume":"10","author":"Crespo-Facorro","year":"2008","journal-title":"Current Psychiatry Report"},{"key":"10.1016\/j.jpsychires.2010.11.002_bib4","unstructured":"Crespo-Facorro B, Perez-Iglesias R, Mata I, Ramirez-Bonilla ML, Martinez-Garcia O, Pardo-Garcia G, et\u00a0al. Effectiveness and efficacy of haloperidol, risperidone and olanzapine in the treatment of first-episode nonaffective psychosis: results of a randomized, controlled 1-year follow-up comparison. Journal of Psychopharmacology, In press."},{"issue":"7474","key":"10.1016\/j.jpsychires.2010.11.002_bib5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/bmj.38246.594873.7C","article-title":"The Lambeth Early Onset (LEO) team: randomised controlled trial of the effectiveness of specialised care for early psychosis","volume":"329","author":"Craig","year":"2004","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jpsychires.2010.11.002_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJMoa002028","article-title":"A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia","volume":"346","author":"Csernansky","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jpsychires.2010.11.002_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0022-3956(98)00024-7","article-title":"Do atypical antipsychotic medications favorably alter the long-term course of schizophrenia?","volume":"32","author":"DeQuardo","year":"1998","journal-title":"Journal of Psychiatric Research"},{"issue":"8","key":"10.1016\/j.jpsychires.2010.11.002_bib8","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4088\/JCP.v66n0810","article-title":"Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study","volume":"66","author":"Dossenbach","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.11.002_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.schres.2006.09.013","article-title":"Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates","volume":"89","author":"Emsley","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2010.11.002_bib10","series-title":"Structured clinical interview for DSM-IV-TR Axis I disorders- non patient edition","author":"First","year":"2001"},{"issue":"3","key":"10.1016\/j.jpsychires.2010.11.002_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpsyc.1995.03950150005001","article-title":"Neuroleptic withdrawal in schizophrenic patients. A review of the literature","volume":"52","author":"Gilbert","year":"1995","journal-title":"Archives of General Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.jpsychires.2010.11.002_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.schres.2010.02.1073","article-title":"A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis","volume":"119","author":"Gleeson","year":"2010","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2010.11.002_bib13","series-title":"ECDEU assessment manual for psychopharmacology","first-page":"217","year":"1976"},{"issue":"3","key":"10.1016\/j.jpsychires.2010.11.002_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archpsyc.57.3.277","article-title":"A program for relapse prevention in schizophrenia: a controlled study","volume":"57","author":"Herz","year":"2000","journal-title":"Archives of General Psychiatry"},{"issue":"3\u20134","key":"10.1016\/j.jpsychires.2010.11.002_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-3956(97)00013-7","article-title":"The limitations of antipsychotic medication on schizophrenia relapse and adjustment and the contributions of psychosocial treatment","volume":"32","author":"Hogarty","year":"1998","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2010.11.002_bib15","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jpsychires.2010.11.002_bib16","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1176\/appi.ajp.160.7.1209","article-title":"Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials","volume":"160","author":"Leucht","year":"2003","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2010.11.002_bib17","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.npp.1300157","article-title":"Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine","volume":"28","author":"Lieberman","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"33","key":"10.1016\/j.jpsychires.2010.11.002_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1192\/S0007125000297717","article-title":"Early intervention, untreated psychosis and the course of early schizophrenia","volume":"172","author":"Linszen","year":"1998","journal-title":"British Journal of Psychiatry (Supplement)"},{"issue":"11","key":"10.1016\/j.jpsychires.2010.11.002_bib19","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1017\/S0033291707002656","article-title":"Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service","volume":"38","author":"Malla","year":"2008","journal-title":"Psychological Medicine"},{"issue":"5","key":"10.1016\/j.jpsychires.2010.11.002_bib20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1017\/S0033291706007379","article-title":"Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study","volume":"36","author":"Malla","year":"2006","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.jpsychires.2010.11.002_bib21","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1176\/appi.ajp.162.5.836","article-title":"The case for practical clinical trials in psychiatry","volume":"162","author":"March","year":"2005","journal-title":"American Journal of Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychires.2010.11.002_bib22","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1176\/appi.ajp.160.8.1405","article-title":"Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes","volume":"160","author":"Marder","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.11.002_bib23","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1016\/j.jpsychires.2010.11.002_bib24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1751-7893.2008.00074.x","article-title":"Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the PAFIP","volume":"2","author":"Pelayo-Teran","year":"2008","journal-title":"Early Intervention in Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2010.11.002_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/schbul\/18.2.185","article-title":"The natural course of schizophrenia: a review of first-admission studies","volume":"18","author":"Ram","year":"1992","journal-title":"Schizophrenia Bulletin"},{"issue":"3","key":"10.1016\/j.jpsychires.2010.11.002_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","article-title":"Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder","volume":"56","author":"Robinson","year":"1999","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2010.11.002_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.ajp.161.3.473","article-title":"Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder","volume":"161","author":"Robinson","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.11.002_bib28","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/appi.ajp.162.5.947","article-title":"Risperidone and haloperidol in first-episode psychosis: a long-term randomised trial","volume":"162","author":"Schooler","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.11.002_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-0447.2005.00659.x","article-title":"Standardized remission criteria in schizophrenia","volume":"113","author":"van Os","year":"2006","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jpsychires.2010.11.002_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/schbul\/17.2.325","article-title":"Neuroleptics and the natural course of schizophrenia","volume":"17","author":"Wyatt","year":"1991","journal-title":"Schizophrenia Bulletin"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395610003201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395610003201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T10:03:05Z","timestamp":1559815385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395610003201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0022395610003201"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2010.11.002","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}